MedTrace Logo

Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer

NCT03167775 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-30

No results posted yet for this study

Summary

Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer

Conditions

  • Advanced Primary Liver Cancer

Interventions

DRUG

Elemene Injection/Elemene Oral Emulusion

Sponsors & Collaborators

  • Dalian Holley Kingkong Pharmaceutical Co., Ltd

    collaborator INDUSTRY

  • BeiJing Yijiayi Medicine Techonoloy Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-28
Primary Completion
2019-05-27
Completion
2019-11-27

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03167775 on ClinicalTrials.gov